Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

New England Journal of Medicine - Tập 382 Số 6 - Trang 545-553 - 2020
Enli Liu1, David Marín1, Pinaki P. Banerjee1, Homer A. Macapinlac2, Philip A. Thompson3, Rafet Başar1, Lucila Nassif Kerbauy1, Bethany J Overman1, Peter F. Thall4, Mecit Kaplan1, Vandana Nandivada1, Indresh Kaur1, Ana Karen Nunez Cortes1, Kai Cao5, May Daher1, Chitra Hosing1, Evan N. Cohen6, Partow Kebriaei1, Rohtesh S. Mehta1, Sattva S. Neelapu7, Yago Nieto1, Michael Wang7, William G. Wierda3, Michael J. Keating3, Richard E. Champlin1, Elizabeth J. Shpall1, Katayoun Rezvani1
1Departments of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston
2Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston.
3Leukemia, University of Texas M. D. Anderson Cancer Center, Houston
4Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston.
5Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston.
6Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston.
7Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1056/NEJMoa1709866

10.1056/NEJMoa1709919

10.1056/NEJMoa1103849

10.1126/scitranslmed.aac5415

10.1200/JCO.2017.72.8519

10.1056/NEJMoa1707447

10.1056/NEJMoa1708566

10.1056/NEJMoa1804980

10.1016/j.bbmt.2018.12.758

10.1126/scitranslmed.3008226

10.1038/nrclinonc.2018.20

10.1038/ni1581

10.1016/S0065-230X(03)90004-2

10.1111/bjh.14570

10.1182/blood-2004-07-2974

10.1200/JCO.2009.24.4590

10.1016/S1074-7613(00)80246-0

10.1038/leu.2017.226

10.1182/asheducation-2016.1.106

10.1182/blood-2017-09-806398

10.1200/JCO.2013.54.8800

10.1038/leu.2010.75

10.1056/NEJMoa1407222

10.1056/NEJMoa1801540

10.1172/jci.insight.96219

10.1182/blood-2009-05-222190

10.1016/j.bcmd.2007.06.029

10.1038/s41591-018-0041-7

10.1016/j.ymthe.2017.06.012

10.1200/JCO.18.02079

10.1200/JCO.19.01113